Bora CDMO Bora CDMO

X

Find Benzazepine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

(+/-)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride
Also known as: 62717-42-4, Skf 38393 hydrochloride, Skf38393 hcl, Skf-38393 hydrochloride, Skf 38393 (hydrochloride), (+/-)-skf-38393 hydrochloride
Molecular Formula
C16H18ClNO2
Molecular Weight
291.77  g/mol
InChI Key
YEWHJCLOUYPAOH-UHFFFAOYSA-N
FDA UNII
WIV5R2G7VP

A selective D1 dopamine receptor agonist used primarily as a research tool.
1 2D Structure

(+/-)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;hydrochloride
2.1.2 InChI
InChI=1S/C16H17NO2.ClH/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,17-19H,6-7,10H2;1H
2.1.3 InChI Key
YEWHJCLOUYPAOH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3.Cl
2.2 Other Identifiers
2.2.1 UNII
WIV5R2G7VP
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-

2. 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine

3. R-sk And F 38393

4. Rsk And F 38393

5. Sk And F 38393

6. Sk And F-38393

7. Sk And F38393

8. Skf 38393

9. Skf 38393 A

10. Skf 38393-a

11. Skf 38393a

12. Skf-38393

13. Skf38393

2.3.2 Depositor-Supplied Synonyms

1. 62717-42-4

2. Skf 38393 Hydrochloride

3. Skf38393 Hcl

4. Skf-38393 Hydrochloride

5. Skf 38393 (hydrochloride)

6. (+/-)-skf-38393 Hydrochloride

7. Skf-38393 Hcl

8. Skf-38393a

9. Wiv5r2g7vp

10. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride

11. 2-phenyl-4-azabicyclo[5.4.0]undeca-7,9,11-triene-9,10-diol

12. (r)-skf 38393 (hydrochloride)

13. Nsc-320959

14. 81633-77-4

15. 62717-42-4 (hcl)

16. 2,3,4,5-tetrahydro-1-phenyl-1h-3-benzazepine-7,8-diol Hydrochloride

17. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride

18. (+/-)-skf-38393 Hydrochloride;skf-38393a

19. Chembl542700

20. Sr-01000075378

21. Skf 38393a

22. Unii-wiv5r2g7vp

23. Skf-38393hydrochloride

24. C16h17no2.hcl

25. Mls000859931

26. Skf 38393 Hcl

27. Schembl3425787

28. (y)-skf-38393 Hydrochloride

29. Dtxsid20936175

30. (?)-skf-38393 Hydrochloride

31. Bcp28880

32. Ex-a3563

33. Tox21_500436

34. 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol Hydrochloride

35. Hy-12520a

36. Nsc320959

37. Akos016012197

38. Ccg-221740

39. Cs-5354

40. Lp00436

41. Nsc 320959

42. Ncgc00093856-01

43. Ncgc00261121-01

44. Ac-32754

45. As-16874

46. Smr000326792

47. D-047

48. Eu-0100436

49. S7993

50. (+/-)-skf-38393 Hydrochloride, Crystalline

51. C75947

52. ( Inverted Question Mark)-skf-38393 Hydrochloride

53. Sr-01000075378-1

54. ( Inverted Exclamation Marka)-skf38393 Hydrochloride

55. ( Inverted Exclamation Marka)-skf-38393 Hydrochloride

56. (+/-)-skf-38393 Hydrochloride D1 Dopamin E Receptor

57. (+/-)-skf-38393 Hydrochloride, Crystalline, >=98% (hplc)

58. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hcl

59. 5-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol;hydrochloride

60. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8- Diol Hydrobromide

61. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hydrochloride

62. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride (1:1)

63. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-,?hydrochloride (1:1)

64. ( Inverted Question Mark)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 291.77 g/mol
Molecular Formula C16H18ClNO2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass291.1026065 g/mol
Monoisotopic Mass291.1026065 g/mol
Topological Polar Surface Area52.5 Ų
Heavy Atom Count20
Formal Charge0
Complexity291
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Dopamine Agonists

Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY